MAZE — Maze Therapeutics, Inc. stock price, charts and financials

QT30Maze Therapeutics, Inc.

Maze Therapeutics, Inc. (NASDAQ: MAZE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
22.52
-0.92-3.92%
OverviewShort InterestFilings
MAZEQT30Maze Therapeutics, Inc.·NASDAQ
22.52-3.92%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 08, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 31, 20264Statement of changes in beneficial ownership
Aug 17, 20268-KCurrent report
Aug 17, 20264Statement of changes in beneficial ownership
Aug 17, 20263Initial statement of beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 17, 20263Initial statement of beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 20264Statement of changes in beneficial ownership
Aug 11, 202610-QQuarterly report
Aug 11, 20268-KCurrent report
Aug 05, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
#1 / 25 of 202
Page
▼
/ 9